Trial · NCT07891767
A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™
NCT07891767, Recruiting, Galderma R&D
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™. Trials, record NCT07891767. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891767
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™
- NCT number
- NCT07891767
- Status
- Recruiting
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Galderma R&D
- Conditions
- Midface Volume Deficit, Midface Contour Deficiency
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence, intensity, duration, and onset of related adverse events (AEs) collected from medical records since first treatment | From the subject's first midface Sculptra treatment to the end of the study, 24 months after the first treatment. | |
| Primary | Incidence, intensity, duration, and onset of related AEs detected during focused physical examinations. | At Day 1 and Month 12 | |
| Primary | Incidence, intensity and duration of pre-defined symptoms collected using a Subject Complaint Questionnaire | At Day 1, Month 6 and Month 12 | |
| Primary | Percentage of subjects in each response category for the Subjects Safety Satisfaction Questionnaire | At Day 1, Month 6 and Month 12 | |
| Primary | Percentage of responders, defined by having "Improved", "Much improved" or "Very much improved" according to the Global Aesthetic Improvement Scale (GAIS) on both sides of the face combined, as assessed by the subject and the investigator | At Day 1 and Month 12 | |
| Primary | Percentage of subjects in each response category for each question in the Subject Effectiveness Satisfaction Questionnaire | At Day 1, Month 6 and Month 12 | |
| Primary | Percentage of subjects in each response category for each question in the Skin Quality Improvement Questionnaire | At Day 1, Month 6 and Month 12 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891767
GET https://conductscience.org/api/trials/v1/NCT07891767/registered